Sponsor Pipeline

Jianxing He Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
1
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
3
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07492342 Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable… Resectable NSCLC Recruiting
NCT07177092 Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung… Non-Small Cell Lung Cancer Not Yet Recruiting
NCT07177105 Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC Non Small Cell Lung Cancer Not Yet Recruiting
Not specified
NCT07110259 AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized… Non Small Cell Lung Caner Not Yet Recruiting
NCT07377123 Tubeless Spontaneous Ventilation Anesthesia in Kidney Transplantation Kidney Transplantation Not Yet Recruiting
NCT07631533 Single-Center Intelligent Pulmonary Rehabilitation After Lung Cancer Surgery Non-Small Cell Lung Cancer Not Yet Recruiting
Disease Areas
Get alerts when Jianxing He's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free